Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Peptides derived from a retrovirus of the HIV group and their use

Peptides derived from a retrovirus of the HIV group and their use

US Patent 6869608 · Granted Mar 22, 2005

Estimated economic value: $15,731,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method for cleavage of solid phase-bound peptides from the solid phase2023
Capping of unprotected amino groups during peptide synthesis2021
Antigenic HIV gp41 chimeric polypeptides comprising the MVP5180/91 epitope SKGKL2010
Antigenic HIV gp41 chimeric polypeptides comprising the MVP5180/91 epitope SKGKL2010
Antigenic HIV gp41 chimeric polypeptides comprising the MVP5180/91 epitope SKGKL2010
Antigenic HIV gp41 chimeric polypeptides comprising the MVP5180/91 epitope SKGKL2010
Retrovirus from the HIV type O and its use (MVP-2901/94)2005
Retrovirus from the HIV type O and its use (MVP-2901/94)2005
Retrovirus from the HIV group and its use2004
Retrovirus from the HIV group and its use2004
Mercaptoacetylamide derivatives, a process for their preparation and their use2003
Lentivirus from the group of immunodeficiency viruses of drill monkeys (Mandrill2003